STONKWHISPER
← Back to Intel
Insider ActivityCRSP

Patel Naimish, Chief Medical Officer at CRISPR Therapeutics AG, sold $211K of CRSP

Updated Jun 18, 2026
Patel Naimish Chief Medical Officer
CRISPR Therapeutics AG · $CRSP
$211K Total Value
3,786 Shares Traded
$55.62 Price / Share
19,357 Shares Owned After
2026-06-01 Filing Date

Transaction Details

InsiderPatel Naimish
TitleChief Medical Officer
CompanyCRISPR Therapeutics AG
TickerCRSP
Transaction TypeSale
Transaction Date2026-05-29
Shares Traded3,786
Price Per Share$55.62
Total Value$211K
Filed Date2026-06-01
Accession Number0001193125-26-251817

Ownership Context

Shares Owned After Transaction19,357
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-251817

Other Insider Trades — CRSP

Other Trades by Patel Naimish

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for CRSP — CRISPR Therapeutics AG →

Whisper Score — CRSP

68.06
Frenzy
Current Whisper Score

See full analysis for CRSP →

Track CRSP insider activity in real time on The Wire →

Get alerts when Patel Naimish files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:06 UTC

Want real-time data? Access The Wire for live sentiment tracking.